rawfin.tv
Agilent Unveils New Lab Workflow for Complex Biologics Analysis
TechnologystocksAI Generated

Agilent Unveils New Lab Workflow for Complex Biologics Analysis

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Agilent Technologies (NYSE: A) has introduced a new multi-attribute method (MAM) workflow designed to address the increasing complexity of biologics. This innovation aims to enhance pharmaceutical and biopharmaceutical research and development.

AgilentBiotechnologyPharmaceuticalsProduct LaunchLife Sciences

Related Articles

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

stocks
S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks